Cogent Biosciences, Inc. (COGT) vs Ligand Pharmaceuticals Incorporated (LGND)

Cogent Biosciences, Inc. and Ligand Pharmaceuticals Incorporated are both Biotechnology companies. Ligand Pharmaceuticals Incorporated is the larger, with a market value of $6.1B against $5.5B — 1.1× the size. Cogent Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 30.1×. Cogent Biosciences, Inc. grew revenue faster over the last twelve months: 110.2% against 54.9%. Ligand Pharmaceuticals Incorporated has the higher net margin (67.9% vs 0.00%) and the higher return on invested capital (8.19% vs 0.00%). Across the 18 metrics below, Ligand Pharmaceuticals Incorporated leads on 15 and Cogent Biosciences, Inc. on 3.